Cooper J B, Foundling S I, Blundell T L, Boger J, Jupp R A, Kay J
Department of Crystallography, Birkbeck College, London, U.K.
Biochemistry. 1989 Oct 17;28(21):8596-603. doi: 10.1021/bi00447a049.
The conformation of a statine-containing renin inhibitor complexed with the aspartic proteinase from the fungus Endothia parasitica (EC 3.4.23.6) has been determined by X-ray diffraction at 2.2-A resolution (R = 0.17). We describe the structure of the complex at high resolution and compare this with a 3.0-A resolution analysis of a bound inhibitor, L-364,099, containing a cyclohexylalanine analogue of statine. The inhibitors bind in extended conformations in the long active-site cleft, and the hydroxyl of the transition-state analogue, statine, interacts strongly with the catalytic aspartates via hydrogen bonds to the essential carboxyl groups. This work provides a detailed structural analysis of the role of statine in peptide inhibitors. It shows conclusively that statine should be considered a dipeptide analogue (occupying P1 to P1') despite lacking the equivalent of a P1' side chain, although other inhibitor residues (especially P2) may compensate by interacting at the unoccupied S1' specificity subsite.
通过X射线衍射在2.2埃分辨率(R = 0.17)下确定了一种含沙他汀的肾素抑制剂与寄生内座壳菌(EC 3.4.23.6)的天冬氨酸蛋白酶形成的复合物的构象。我们描述了该复合物的高分辨率结构,并将其与含有沙他汀环己基丙氨酸类似物的结合抑制剂L-364,099的3.0埃分辨率分析进行比较。抑制剂以伸展构象结合在长的活性位点裂隙中,过渡态类似物沙他汀的羟基通过与必需羧基的氢键与催化天冬氨酸强烈相互作用。这项工作提供了沙他汀在肽抑制剂中作用的详细结构分析。它确凿地表明,尽管缺乏相当于P1'侧链的结构,但沙他汀应被视为二肽类似物(占据P1至P1'),尽管其他抑制剂残基(特别是P2)可能通过在未占据的S1'特异性亚位点相互作用来进行补偿。